Filing Details
- Accession Number:
- 0001209191-20-065414
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-29 18:58:35
- Reporting Period:
- 2020-12-24
- Accepted Time:
- 2020-12-29 18:58:35
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1340652 | Chemocentryx Inc. | CCXI | Pharmaceutical Preparations (2834) | 943254365 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1648283 | A. Thomas Edwards | C/O Chemocentryx, Inc. 850 Maude Avenue Mountain View CA 94043 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-12-24 | 14,218 | $61.18 | 152,139 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-12-28 | 10,782 | $61.50 | 141,357 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $61.09 to $61.41 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.